In-vitro and in-vivo performance studies of a porous infusion catheter designed for intraparenchymal delivery of therapeutic agents of varying size-Reference-Cited by-同舟云学术

In-vitro and in-vivo performance studies of a porous infusion catheter designed for intraparenchymal delivery of therapeutic agents of varying size

Published:2022-08 Issue: Volume:378 Page:109643
ISSN:0165-0270
Container-title:Journal of Neuroscience Methods
language:en
Short-container-title:Journal of Neuroscience Methods

Author:

Brady Martin L.,Grondin Richard,Zhang Zhiming,Pomerleau Francois,Powell David,Huettl Pete,Wilson Mike,Stice Jim,Gerhardt Greg A.,Abramov Vasiliy,Raghavan Raghu

Funder

Small Business Innovation Research

National Institutes of Health

Publisher

Elsevier BV

Subject

General Neuroscience

Reference24 articles.

1. Convection enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations;Barua;Brain Pathol.,2014

2. Physical characterization of neurocatheter performance in a brain phantom gelatin with nanoscale porosity;Bauman;Nanotechnology,2004

3. Convection-enhanced delivery of macromolecules in the brain;Bobo;Proc. Natl. Acad. Sci. USA,1994

4. Quantifying fluid infusions and tissue expansion in brain;Brady;IEEE Trans. Biomed. Eng.,2011

5. In vivo performance of a microfabricated catheter for intraparenchymal delivery;Brady;J. Neurosci. Methods,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic Interfaces for Chronic Bidirectional Access to the Brain;Advanced Healthcare Materials;2024-06-26

2. Adjuvant convection-enhanced delivery for the treatment of brain tumors;Journal of Neuro-Oncology;2024-01

3. A Biphasic Fluid–Structure Interaction Model of Backflow During Infusion Into Agarose Gel;Journal of Biomechanical Engineering;2023-10-26

4. Microfluidic interfaces for chronic bidirectional access to the brain;2023-09-22

5. H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics;Expert Opinion on Therapeutic Targets;2023-01-02